192 related articles for article (PubMed ID: 14871216)
1. Locoregional cutaneous metastases of malignant melanoma and their management.
Wolf IH; Richtig E; Kopera D; Kerl H
Dermatol Surg; 2004 Feb; 30(2 Pt 2):244-7. PubMed ID: 14871216
[TBL] [Abstract][Full Text] [Related]
2. Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
Rivas-Tolosa N; Ortiz-Brugués A; Toledo-Pastrana T; Baradad M; Traves V; Soriano V; Sanmartín V; Requena C; Martí R; Nagore E
J Dermatol; 2016 May; 43(5):553-6. PubMed ID: 26660713
[TBL] [Abstract][Full Text] [Related]
3. Are locoregional cutaneous metastases in melanoma predictable?
Borgstein PJ; Meijer S; van Diest PJ
Ann Surg Oncol; 1999; 6(3):315-21. PubMed ID: 10340893
[TBL] [Abstract][Full Text] [Related]
4. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Florin V; Desmedt E; Vercambre-Darras S; Mortier L
Invest New Drugs; 2012 Aug; 30(4):1641-5. PubMed ID: 21748297
[TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread.
Ugurel S; Wagner A; Pföhler C; Tilgen W; Reinhold U
Br J Dermatol; 2002 Sep; 147(3):621-4. PubMed ID: 12207622
[No Abstract] [Full Text] [Related]
7. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
8. Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
Vereecken P; Mathieu A; Laporte M; Petein M; Velu T; Awada A; Heenen M
Dermatology; 2003; 206(3):279-80. PubMed ID: 12673091
[No Abstract] [Full Text] [Related]
9. Topical imiquimod in the treatment of metastatic melanoma to skin.
Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
[No Abstract] [Full Text] [Related]
10. Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment.
Kowalzick L; Eickenscheidt L
J Dtsch Dermatol Ges; 2009 Jun; 7(6):538-40. PubMed ID: 19298548
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
Park AJ; Paul J; Chapman MS; Samie FH
Dermatol Surg; 2017 Aug; 43(8):1017-1022. PubMed ID: 28328708
[TBL] [Abstract][Full Text] [Related]
12. In-transit melanoma: an individualized approach.
Grotz TE; Mansfield AS; Kottschade LA; Erickson LA; Otley CC; Markovic SN; Jakub JW
Oncology (Williston Park); 2011 Dec; 25(14):1340-8. PubMed ID: 22329185
[TBL] [Abstract][Full Text] [Related]
13. Treatment of locally metastatic melanoma: a novel approach.
Shistik G; Prakash AV; Fenske NA; Glass LF
J Drugs Dermatol; 2007 Aug; 6(8):830-2. PubMed ID: 17763615
[TBL] [Abstract][Full Text] [Related]
14. Topical imiquimod clears invasive melanoma.
Grady BE; Spencer JM
Cutis; 2016 Nov; 98(5):E28-E30. PubMed ID: 28040822
[TBL] [Abstract][Full Text] [Related]
15. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
Tas F; Erturk K
Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
[TBL] [Abstract][Full Text] [Related]
16. Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.
Read T; Webber S; Thomas J; Wagels M; Schaider H; Soyer HP; Smithers BM
BMJ Open; 2017 Oct; 7(10):e016816. PubMed ID: 28988173
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
Mauldin IS; Wages NA; Stowman AM; Wang E; Olson WC; Deacon DH; Smith KT; Galeassi N; Teague JE; Smolkin ME; Chianese-Bullock KA; Clark RA; Petroni GR; Marincola FM; Mullins DW; Slingluff CL
Cancer Immunol Immunother; 2016 Oct; 65(10):1201-12. PubMed ID: 27522582
[TBL] [Abstract][Full Text] [Related]
18. [Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
Marcoval J; Ferreres JR; Penín RM; Piulats JM; Caminal JM; Fabra A
Actas Dermosifiliogr; 2011 Dec; 102(10):791-6. PubMed ID: 21658662
[TBL] [Abstract][Full Text] [Related]
19. Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
Ocampo-Garza J; Gioia Di Chiacchio N; Haneke E; le Voci F; Paschoal FM
J Drugs Dermatol; 2017 Mar; 16(3):268-270. PubMed ID: 28301623
[TBL] [Abstract][Full Text] [Related]
20. Clearance of invasive melanoma with topical imiquimod.
Moon SD; Spencer JM
J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]